ERNAW
Ernexa Therapeutics Inc.
NASDAQ · Financial Services · Asset Management · US
$0.02
−15.02%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-383.0%
Return on equity
-194.1%
Return on assets
-330.7%
Return on invested capital
0.00x
Asset turnover
-$8.8M
Cash from operations
$0.64
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026